REQUEST A DEMO
Total
USD $0.00
Search more companies

HBM Holdings Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: HBM Holdings Limited Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

HBM Holdings Limited is a limited company established by Anhui Aikelan Energy-saving Environmental Protection Technology Co., Ltd. on January 8, 2009. The company was formed through a cooperation agreement between Jin Qiao Company, Liu Yi, Zhu Qing, and Zhou Hongchang, as well as the company's articles of association. The registered capital of HBM Holdings Limited is 5 million RMB. According to the agreement and articles of association, Jin Qiao Company contributed 2.45 million RMB in monetary investment, accounting for 49% of the registered capital. Liu Yi contributed 1.159 million RMB, with 0.568 million RMB in monetary investment and 0.591 million RMB in technological investment, totaling 23.18% of the registered capital. Zhu Qing contributed 0.6955 million RMB, with 0.341 million RMB in monetary investment and 0.3545 million RMB in technological investment, totaling 13.91% of the registered capital. Zhou Hongchang also contributed 0.6955 million RMB, with 0.341 million RMB in monetary investment and 0.3545 million RMB in technological investment, totaling 13.91% of the registered capital. On January 20, 2009, the Chizhou Municipal Bureau of Commerce issued a reply approving the establishment of the limited company. On the same day, the Anhui Provincial People's Government issued a "Certificate of Approval for Foreign-Invested Enterprises in the People's Republic of China" to Aikelan Limited (Certificate No. 3400008372). On January 21, 2009, the Chizhou Municipal Administration for Industry and Commerce registered the limited company and issued a "Business License" (Registration No. 341700400001892).

Headquarters
12Th Floor, Tower A, Fenglin International Plaza Phase Ii, 420 Fenglin Road, Xuhui District
Shanghai; Shanghai;

Contact Details: Purchase the HBM Holdings Limited report to view the information.

Website: http://www.harbourbiomed.com

Basic Information
Total Employees:
Purchase the HBM Holdings Limited report to view the information.
Outstanding Shares:
Purchase the HBM Holdings Limited report to view the information.
Registered Capital:
Purchase the HBM Holdings Limited report to view the information.
Financial Auditors:
Purchase the HBM Holdings Limited report to view the information.
Incorporation Date:
July 20, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
12.18%
Purchase this report to view the information.
8.93%
Purchase this report to view the information.
7.86%
Purchase this report to view the information.
6.59%
Purchase this report to view the information.
0.15%
Subsidiaries
Harbour Antibodies Bv (Netherlands)
100%
Harbour Biomed Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after HBM Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
48.37%
Total operating revenue
60.05%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-16.7%
Total equity
-35.99%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
43.78%
Quick Ratio
-0.82%
Cash Ratio
-0.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?